VAERS Reports U011993

VAERS 2366571

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

schwer

Staat: WI
Alter: 17,0
Geschlecht: F
Eingang: 12.07.2022
Impfdatum: 29.06.2022
Beginn: 29.06.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal discomfort Abdominal pain upper Arthralgia Back pain Blood test normal Computerised tomogram normal Deafness Disorientation Dizziness Electrocardiogram normal Fall Feeling abnormal Headache Loss of consciousness Neck pain Pain in extremity Palpitations Presyncope

Symptomtext

MMR vaccination administered into left posterior arm. Mom and patient were directed to front desk to schedule 2nd vaccine. While in line to schedule, patient stated her heart was racing and felt dizzy. She "collapsed" onto floor. Patient was disoriented when coming to. When VS were obtained and stable, she was sent home. Over next several days, Patient struggled with headaches, severe stomach pain, aches in neck, back, hips and legs. Patient slept several hours during the day and felt "groggy". Day 6, the patient was at work when her head started to feel "spacey," and she describes that her stomach started feeling "sick" and "squeezing." She was able to walk to the break room, sat down, and passed out. The patient does note that she was losing her hearing before losing consciousness. She fell onto her right side. The patient states that she "probably" hit her head on the ground. The patient does not know how long she was unconscious for. The patient went to the ER after the second incident. All blood work, EKG and CT reported normal findings. Vasovagal syncope was noted as likely contributing to her symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: July 5, 2022 - All blood work, EKG and CT reported normal findings. Vasovagal syncope was noted as likely contributing to her symptoms.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2448056

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

mild

Staat: CA
Alter: 17,0
Geschlecht: F
Eingang: 16.09.2022
Impfdatum: 16.09.2022
Beginn: 16.09.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness

Symptomtext

Patient was extremely nervous prior to receiving vaccinations. After receiving the vaccinations, the patient stated she was feeling lightheaded and dizzy. The nurse laid her down and put her feet/legs up on the chair. Dr. was called to assess. Moved patient to the faint cot and raised her legs up for circulation. After a few minutes, the patient was feeling better. BP monitored throughout event and stable. Patient was released home with her brother and mother with ER precautions explained.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Dizziness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2414676

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

mild

Staat: AZ
Alter: 6,0
Geschlecht: M
Eingang: 18.08.2022
Impfdatum: 01.08.2022
Beginn: 01.08.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SC / RL

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Rash Urticaria

Symptomtext

13+ rash/hives over several parts of body

Weitere VAERSDATA-Felder

Praegender Schweregrund: Rash
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Fluoride rinse and probiotic daily
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2687558

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

gering

Staat: MO
Alter: -
Geschlecht: U
Eingang: 28.09.2023
Impfdatum: 13.07.2023
Beginn: 13.07.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered

Symptomtext

No other AE; Caller reported an AE for MMRII. The caller said the product was administered on 7/13/2023 after the labeled expiration date. Confirmed with caller no other AE occurred. Confirmed no temperature excursion occurred prior to administration. AE letter s; This spontaneous report has been received from an office manager, concerning to a 12-month-old patient of unknown gender. The patient's concurrent conditions, medical history and concomitant medications were not provided. On 13-JUL-2023, the patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (strength, dose, dose number, route of administration, anatomical location were not provided) (lot#: U011993, expiration date: 15-APR-2023) (albumin status: rHA) (expired product administered). No other adverse event occurred and there was no temperature excursion prior to the administration. No further information was provided.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2631390

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

gering

Staat: OH
Alter: -
Geschlecht: U
Eingang: 13.05.2023
Impfdatum: 04.05.2023
Beginn: 04.05.2023
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

Confirmed with caller no other AE occurred.; a dose of MMRII was administered after the expiration date on 5/4/2023.; This spontaneous report was received from an administrator regarding a patient of an unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 04-MAY-2023, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneous injection, 1 dose, lot #U011993, expiration date: 15-APR-2023, administered as prophylaxis (strength, dosage regimen, anatomical location, and route of administration were not provided) (Expired product administered). No adverse events were reported. .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2631787

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

gering

Staat: IA
Alter: 71,0
Geschlecht: F
Eingang: 12.05.2023
Impfdatum: 14.06.2022
Beginn: -
Tage bis Beginn: -
Dosis: 3
Route/Site: SC / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Extra dose administered No adverse event

Symptomtext

*No adverse event or reaction occurred* Extra dose was given Pt was inadvertently given a 3rd dose 1 week 6/14/2022 after the 2nd dose was given 6/7/2022 Miscommunication among staff members Pt has had no complaints or problems.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Extra dose administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2628578

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 08.05.2023
Impfdatum: 17.04.2023
Beginn: 17.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE/No adverse effects reported; HCP called to report inadvertent administration of an expired dose of MMR II. Dose expired on 4/15/2023, and was administered today (4/17/2023). No adverse effects reported. No additional AE/No PQC.; This spontaneous report was received from a medical assistant and refers to a patient of unspecified demographics . There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 17-APR-2023, the patient was inadvertently vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (recombinant human albumin) (M-M-R II) injection, 0.5 mL, lot# U011993 with expiration date 15-APR-2023 (dose number, frequency, route and site of administration were not reported) for prophylaxis (expired product administered). No adverse effects were reported (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2625164

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

gering

Staat: TX
Alter: -
Geschlecht: U
Eingang: 03.05.2023
Impfdatum: 21.04.2023
Beginn: 21.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE reported; HCP reported a dose of MMR II was inadvertently administered after the labeled expiration date. Caller stated the dose was administered on 21-APR-2023, but expired on 15-APR-2023. No additional informaion provided. Additional AE case 02376568 filed.; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 21-APR-2023, the patient was inadvertently vaccinated after the labeled expiration date with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (rHA) subcutaneous injection, at a dose of 0.5 mL, lot #U011993, expiration date: 15-APR-2023, administered for prophylaxis (strength, and route of administration were not provided). The dose was administered on 21-APR-2023 but expired on 15-APR-2023 (expired product administered). No additional AEs or PQC were reported (no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2623137

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge U011993

gering

Staat: OH
Alter: 11,0
Geschlecht: F
Eingang: 28.04.2023
Impfdatum: 31.05.2022
Beginn: 31.05.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Immunisation reaction

Symptomtext

Adverse effect of other vaccines and biological substances, initial encounter on 2022-05-31.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Immunisation reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Learning disorder NOS; Attention-deficit hyperactivity disorder NOS; Mild intermittent asthma NOS; Immunization not carried out for unspecified reason; Body mass index [BMI] pediatric, 5th percentile to less than 85th percentile for age; Encounter for issue of repeat prescription; Urticaria, unspecified; Body mass index [BMI] pediatric, 5th percentile to less than 85th percentile for age
Vorgeschichte: -
Andere Medikamente: None
Allergien: -
Vorherige Impfungen: -

VAERS 2621774

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

gering

Staat: MD
Alter: -
Geschlecht: U
Eingang: 26.04.2023
Impfdatum: 24.04.2023
Beginn: 24.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

Confirmed with caller no AE occurred; Caller reported an AE for MMRII. The caller said an expired dose was administered to a patient on 4/24/2023.; This spontaneous report has been received from a medical assistant, regarding a patient of unknown age and gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported. On 24-APR-2023, the patient was vaccinated with an expired dose of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) subcutaneous injection, as prophylaxis (lot number: U011993, which was determined to be valid, with an expiration date on 15-APR-2023, therapy type rHA) (strength, dose, scheme, route and anatomical location of administration were not reported) (Expired product administered). Caller said the product did not have any temperature excursions prior to administration. No additional adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2621772

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U011993

gering

Staat: TX
Alter: -
Geschlecht: U
Eingang: 26.04.2023
Impfdatum: 21.04.2023
Beginn: 21.04.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No additional AE reported; dose of MMR II was inadvertently administered after the labeled expiration date.; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. No information on patient medical history, current conditions and concomitant medications was provided. On 21-APR-2023 the patient was vaccinated with 0.5 milliliters of expired measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # U011993 and expiration date 15-APR-2023 for prophylaxis (route of administration was not provided) (expired product administered and no adverse event).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2278321

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u011993

gering

Staat: VA
Alter: 22,0
Geschlecht: M
Eingang: 16.05.2022
Impfdatum: 16.05.2022
Beginn: 16.05.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Incorrect route of product administration No adverse event

Symptomtext

RN gave Varicella and MMR vaccines intra-muscular vs subcutaneous. Patient did not experience an adverse event after receiving the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Incorrect route of product administration
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -